Skip to content

Inspection Record

Center for Translational Medicine — FDA 483 Findings

US FDAInspected 2025-07-11Published 2026-10-27 5 findingsLaboratory and QC controlsOther quality system

View the regulator's official source The source document is always the basis for judgement.

Findings

1Laboratory and QC controls

The quality assurance unit failed to maintain a copy of a master schedule sheet that contained all required elements for all nonclinical laboratory studies conducted by the testing facility.

2Other quality system

The final study report did not include a description of all circumstances that may have affected the quality or integrity of the data.

3Other quality system

Standard operating procedures have not been established for test system observations and handling of (b) (4) (b) (4) or (©) (4) during study.

4Other quality system

The study director failed to assure that all raw data, documentation, protocols, specimens, and final reports were transferred to the archives during or at the close of the study.

5Other quality system

The study director failed to assure that the protocol, including any change, was approved and was followed.

Similar findings at other companies

GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.

A record as of the US FDA document published on 2026-10-27. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.

Center for Translational Medicine company profile — full historyAll US FDA findings US FDA documents, 2026 Go to Findings search
Linked from (backlinks)
Briefs that featured this document
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.